The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000375:Aging; D014151:Anti-Anxiety Agents / Q000378:metabolism*; D002707:Chlordiazepoxide / Q000378:metabolism*; D003975:Diazepam / Q000378:metabolism*; D005260:Female; D006207:Half-Life; D006525:Hepatitis, Viral, Human / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D008104:Liver Cirrhosis, Alcoholic / Q000378:metabolism; D008107:Liver Diseases / Q000378:metabolism*; D008140:Lorazepam / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010076:Oxazepam / Q000378:metabolism*
D014151:Anti-Anxiety Agents; D010076:Oxazepam; D002707:Chlordiazepoxide; D008140:Lorazepam; D003975:Diazepam